Rocket Pharmaceuticals
RCKT
#6382
Rank
A$0.95 B
Marketcap
$8.96
Share price
-11.75%
Change (1 day)
-76.85%
Change (1 year)

Earnings for Rocket Pharmaceuticals (RCKT)

Earnings in 2024 (TTM): -A$0.4 Billion

According to Rocket Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rocket Pharmaceuticals from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.42 Billion5.35%
2023 -A$0.4 Billion10.7%
2022 -A$0.36 Billion31.23%
2021 -A$0.28 Billion21.02%
2020 -A$0.23 Billion80.79%
2019 -A$0.13 Billion3.69%
2018 -A$0.13 Billion323.4%
2017 -A$28.37 Million-58.93%
2016 -A$69.08 Million-36.96%
2015 -A$0.11 Billion613.27%
2014 -A$15.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion-44.77%๐Ÿ‡บ๐Ÿ‡ธ USA